Search

everythinglearnresearchcommunity

for

Search:↓

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Nanocarriers with spironolactone and 2-deoxy-D-ribose may improve hair loss treatment by targeting hair follicles directly.

Baricitinib can cause excessive hair growth.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Nilotinib can cause keratosis pilaris, a skin condition.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

Some birth control pills can cause hair loss, and switching to ones with less androgen should help.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

A woman developed male characteristics after using unregulated hormone therapy.

The new compound may be a safer alternative to finasteride for prostate protection.

A new compound effectively inhibits human 5α-reductase 1.

Finasteride may reduce prostate cancer risk.

The compound 4c showed strong potential as an anticancer agent.

Estetrol may help prevent hair loss and support hair growth in women.

Bicalutamide shows promise for treating female hair loss.

Transcranial electrical stimulation with bisphosphonates helps maintain bone collagen better than bisphosphonates alone.

Serenoa repens extract shows promise as a natural treatment for prostate cancer.

The method identified and measured ten compounds from Eclipta prostrata, showing significant enzyme inhibitory effects.